Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells
Graft engineering by CD34+ selection of peripheral blood progenitor cells (PBPC) has been used in non-Hodgkin lymphoma (NHL) with the aim to reduce relapse related to tumor cells within the graft. From September 1995 to January 2000, 39 patients with newly diagnosed (n = 31) or relapsed (n = 8) NHL...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
[January 2007]
|
| In: |
Stem cells
Year: 2007, Jahrgang: 25, Heft: 1, Pages: 228-235 |
| ISSN: | 1549-4918 |
| DOI: | 10.1634/stemcells.2005-0613 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1634/stemcells.2005-0613 Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1634/stemcells.2005-0613 
|
| Verfasserangaben: | Mathias Witzens-Harig, Conny Heilmann, Manfred Hensel, Martin Kornacker, Axel Benner, Rainer Haas, Stefan Fruehauf, Anthony D. Ho |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1776270673 | ||
| 003 | DE-627 | ||
| 005 | 20230428085620.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 211105s2007 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1634/stemcells.2005-0613 |2 doi | |
| 035 | |a (DE-627)1776270673 | ||
| 035 | |a (DE-599)KXP1776270673 | ||
| 035 | |a (OCoLC)1341423408 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Witzens-Harig, Mathias |e VerfasserIn |0 (DE-588)1050736516 |0 (DE-627)784812322 |0 (DE-576)404988970 |4 aut | |
| 245 | 1 | 0 | |a Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells |c Mathias Witzens-Harig, Conny Heilmann, Manfred Hensel, Martin Kornacker, Axel Benner, Rainer Haas, Stefan Fruehauf, Anthony D. Ho |
| 246 | 3 | 3 | |a Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34 + -selected peripheral blood prog |
| 264 | 1 | |c [January 2007] | |
| 300 | |b Diagramme | ||
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Das Pluszeichen im Titel ist hochgestellt | ||
| 500 | |a Frontdoor: First published: 02 January 2009 | ||
| 500 | |a Gesehen am 05.11.2021 | ||
| 520 | |a Graft engineering by CD34+ selection of peripheral blood progenitor cells (PBPC) has been used in non-Hodgkin lymphoma (NHL) with the aim to reduce relapse related to tumor cells within the graft. From September 1995 to January 2000, 39 patients with newly diagnosed (n = 31) or relapsed (n = 8) NHL were treated in our institution with myeloablative therapy followed by CD34+ selected autologous PBPC transplantation. Thirty-one patients were diagnosed with follicular lymphoma, and eight patients with mantle-cell lymphoma. All patients had advanced disease (26% of patients stage III and 74% stage IV, Ann Arbor classification). Induction therapy resulted in a complete remission in 17 patients and a partial remission in 22 patients. PBPC were mobilized after cytotoxic chemotherapy with granulocyte colony-stimulating factor support. CD34+ selection was performed using immunomagnetic beads (Baxter Isolex 300SA or 300i Magnetic Cell Separation System). Most patients (85%) received total body irradiation and high-dose cyclophosphamide as myeloablative regimen. Twelve patients also received rituximab 375 mg/m2 before radiation and before the start of the cyclophosphamide treatment. The mean CD34+ cell number for transplantation was 6.5 × 106 CD34+ cells/kg of body weight. Platelet recovery (>20,000/μl median on day 13) and leukocyte recovery (>1,000/μl median on day 12) were within expected range. The estimated median follow-up was 47 months. The probabilities of freedom from progression, overall survival, and event-free survival 4 years after transplantation were 96%, 90%, and 87%, respectively, for patients with follicular lymphoma and 42%, 63%, and 33%, respectively, for patients with mantle-cell lymphoma. Risk factors for relapse were age and extranodal manifestation of disease. The rate of lethal infections in the 12-month follow-up period was 8%. We conclude that CD34+ selection of autologous transplants following myeloablative therapy is feasible and results in long-term remission in the majority of patients, but the procedure is probably related to a higher rate of lethal infections. | ||
| 650 | 4 | |a CD34+-selected PBPC | |
| 650 | 4 | |a Graft engineering | |
| 650 | 4 | |a High-dose chemotherapy | |
| 650 | 4 | |a Long-term follow-up | |
| 650 | 4 | |a Lymphoma | |
| 700 | 1 | |a Heilmann, Conny Yvonne Xenia |d 1979- |e VerfasserIn |0 (DE-588)133148297 |0 (DE-627)537507132 |0 (DE-576)299654982 |4 aut | |
| 700 | 1 | |a Hensel, Manfred |d 1964- |e VerfasserIn |0 (DE-588)1065849729 |0 (DE-627)816878307 |0 (DE-576)425541908 |4 aut | |
| 700 | 1 | |a Kornacker, Martin |d 1966- |e VerfasserIn |0 (DE-588)11573774X |0 (DE-627)691553858 |0 (DE-576)290048524 |4 aut | |
| 700 | 1 | |a Benner, Axel |d 1959- |e VerfasserIn |0 (DE-588)106584686X |0 (DE-627)81687221X |0 (DE-576)425536602 |4 aut | |
| 700 | 1 | |a Haas, Rainer |d 1955- |e VerfasserIn |0 (DE-588)173773524 |0 (DE-627)698678141 |0 (DE-576)134613805 |4 aut | |
| 700 | 1 | |a Frühauf, Stefan |d 1964- |e VerfasserIn |0 (DE-588)113078676 |0 (DE-627)618240306 |0 (DE-576)317921320 |4 aut | |
| 700 | 1 | |a Ho, Anthony Dick |d 1948- |e VerfasserIn |0 (DE-588)108692477 |0 (DE-627)504904205 |0 (DE-576)19010466X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Stem cells |d Oxford : Oxford University Press, 1993 |g 25(2007), 1 vom: Jan., Seite 228-235 |h Online-Ressource |w (DE-627)324746296 |w (DE-600)2030643-X |w (DE-576)106890816 |x 1549-4918 |7 nnas |a Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells |
| 773 | 1 | 8 | |g volume:25 |g year:2007 |g number:1 |g month:01 |g pages:228-235 |g extent:8 |a Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells |
| 856 | 4 | 0 | |u https://doi.org/10.1634/stemcells.2005-0613 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1634/stemcells.2005-0613 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20211105 | ||
| 993 | |a Article | ||
| 994 | |a 2007 | ||
| 998 | |g 108692477 |a Ho, Anthony Dick |m 108692477:Ho, Anthony Dick |d 910000 |d 910100 |e 910000PH108692477 |e 910100PH108692477 |k 0/910000/ |k 1/910000/910100/ |p 8 |y j | ||
| 998 | |g 113078676 |a Frühauf, Stefan |m 113078676:Frühauf, Stefan |d 50000 |e 50000PF113078676 |k 0/50000/ |p 7 | ||
| 998 | |g 106584686X |a Benner, Axel |m 106584686X:Benner, Axel |d 50000 |e 50000PB106584686X |k 0/50000/ |p 5 | ||
| 998 | |g 1065849729 |a Hensel, Manfred |m 1065849729:Hensel, Manfred |d 910000 |d 910100 |e 910000PH1065849729 |e 910100PH1065849729 |k 0/910000/ |k 1/910000/910100/ |p 3 | ||
| 998 | |g 133148297 |a Heilmann, Conny Yvonne Xenia |m 133148297:Heilmann, Conny Yvonne Xenia |d 50000 |e 50000PH133148297 |k 0/50000/ |p 2 | ||
| 998 | |g 1050736516 |a Witzens-Harig, Mathias |m 1050736516:Witzens-Harig, Mathias |d 910000 |d 910100 |e 910000PW1050736516 |e 910100PW1050736516 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1776270673 |e 3999372281 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"origin":[{"dateIssuedDisp":"1993-","publisherPlace":"Oxford ; Miamisburg, Ohio ; Hoboken, NJ","publisher":"Oxford University Press ; AlphaMed Press ; Wiley-Blackwell","dateIssuedKey":"1993"}],"id":{"zdb":["2030643-X"],"issn":["1549-4918"],"eki":["324746296"],"doi":["10.1002/(ISSN)1549-4918"]},"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"issue":"1","extent":"8","year":"2007","text":"25(2007), 1 vom: Jan., Seite 228-235","pages":"228-235","volume":"25"},"title":[{"title_sort":"Stem cells","title":"Stem cells","subtitle":"the international journal of cell differentiation and proliferation"}],"physDesc":[{"extent":"Online-Ressource"}],"disp":"Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cellsStem cells","note":["Gesehen am 22.04.2022"],"pubHistory":["11.1993 -"],"recId":"324746296"}],"language":["eng"],"id":{"doi":["10.1634/stemcells.2005-0613"],"eki":["1776270673"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"name":{"displayForm":["Mathias Witzens-Harig, Conny Heilmann, Manfred Hensel, Martin Kornacker, Axel Benner, Rainer Haas, Stefan Fruehauf, Anthony D. Ho"]},"recId":"1776270673","note":["Das Pluszeichen im Titel ist hochgestellt","Frontdoor: First published: 02 January 2009","Gesehen am 05.11.2021"],"person":[{"family":"Witzens-Harig","display":"Witzens-Harig, Mathias","given":"Mathias","role":"aut"},{"family":"Heilmann","display":"Heilmann, Conny Yvonne Xenia","given":"Conny Yvonne Xenia","role":"aut"},{"family":"Hensel","display":"Hensel, Manfred","given":"Manfred","role":"aut"},{"role":"aut","family":"Kornacker","display":"Kornacker, Martin","given":"Martin"},{"role":"aut","given":"Axel","display":"Benner, Axel","family":"Benner"},{"given":"Rainer","display":"Haas, Rainer","family":"Haas","role":"aut"},{"role":"aut","display":"Frühauf, Stefan","family":"Frühauf","given":"Stefan"},{"display":"Ho, Anthony Dick","family":"Ho","given":"Anthony Dick","role":"aut"}],"physDesc":[{"extent":"8 S.","noteIll":"Diagramme"}],"titleAlt":[{"title":"Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34 + -selected peripheral blood prog"}],"title":[{"title":"Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells","title_sort":"Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells"}],"origin":[{"dateIssuedDisp":"[January 2007]","dateIssuedKey":"2007"}]} | ||
| SRT | |a WITZENSHARLONGTERMFO2007 | ||